Groupe d'Études et de Recherche Clinique en Rhumatologie

The Groupe d'Études et de Recherche Clinique en Rhumatologie (GERC) is a French clinical research organization dedicated to advancing the field of rheumatology through high-quality multicenter clinical trials. The group specializes in the design, coordination, and management of studies focusing on inflammatory rheumatic diseases, including rheumatoid arthritis and spondyloarthritis. GERC provides a comprehensive suite of services for clinical research, including protocol development, regulatory management, and data analysis. By bridging the gap between academic expertise and pharmaceutical development, GERC plays a vital role in evaluating the safety and efficacy of innovative biotherapies and small molecules. The organization consists of a network of expert rheumatologists across France, ensuring robust clinical excellence and data collection for Phase 2 through Phase 4 trials.